New Jersey Taxotere Lawyer​

Taxotere (chemical name docetaxel) is a chemotherapy drug doctors often combine with other chemo medications to prevent cancer cells from dividing. Doctors may use Taxotere to treat early-stage breast cancer if it has spread to the lymph nodes or advanced-stage breast cancer that has spread through the body after treatment or surgery. If cancer cells don’t respond to doxorubicin, Taxotere may also be a treatment option. Doctors administer Taxotere intravenously during chemotherapy treatments, often after surgery.

While Taxotere has many side effects listed, permanent hair loss (alopecia) is not one of them. Many men and women who agreed to receive Taxotere as part of breast cancer treatment say that no one ever warned them about the risk of permanent hair loss — not the physician or the drug manufacturing company (Sanofi-Aventis U.S. LLC). While the specifications for Taxotere warn patients of the risk of “hair loss,” it does not state anywhere that this risk could be permanent. Now, thousands of breast cancer survivors are going up against Taxotere’s manufacturer in pursuit of damages, with four cases going to trial in 2019.

Men and women filing claims against Sanofi-Aventis U.S. LLC have sought financial compensation for their hair loss-related emotional distress, mental anguish, loss of work, psychological damage and other harms. They allege that the company knew of the link between using Taxotere and suffering irreversible hair loss but did not warn patients. As the number of claims involving Taxotere continues to grow, the courts have consolidated many lawsuits into multidistrict litigations (MDLs). Speak with a New Jersey mass torts attorney to learn if you could be eligible to join an MDL from New Jersey if you took Taxotere and suffered permanent baldness.